Citius Pharma (CTXR) $2.15. Price Target of $8.00 Maintained, Post Safety and Efficacy Review.
Investment Banker Buy Rating Maintained: DSMB Gives the Thumbs Up – Data in Early 2022.
CITIUS NEWS ARCHIVE
Citius announced that the DMC interim safety and...
Ehave (EHVVF) Looks to Power the Psychedelics Revolution
Mental illness will cost the global economy $16 trillion by 2030 due to early-onset and lost productivity, with an estimated 12 billion working days lost due...
Ehave (EVVHF) Hires Institutional Review Board (IRB) As It Solidifies Partnership With Tristar Wellness...
Institutional Review Board (IRB) reviews proposed research protocols to protect human subjects involved in research.
MIAMI, July 09, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC...
Psychedelic Investor Conferences.
Not Quite as Popular as the Bitcoin 2021 Conference Attended by 12,000 - But Worth Considering!
Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit (July...
Preventing Type I Diabetes. Here’s How Provention (PRVB) Works.
Here's How Provention's Treatment Works.
Interview With an Actual Provention Bio (PRVB) Clinical Trial Participant.
Conversation Between a Mikayla a Teenager who was at...
Psychedelic Primer Guide. (Psychedelic Medicine Association)
The Psychedelic Medicine Association (PMA) is a society of physicians, therapists, and health care professionals looking to advance their education on the therapeutic uses...
Greenbrook Health Centers (GBNH) Changing the Way Depression is Treated.
Cybin Enters into Collaboration Agreement with Greenbrook TMS to Establish Mental Health Centers of Excellence
https://youtu.be/yrr-wlFftT0
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology...
Citius (CTXR). Dang Flippers!
Short term investors powered Citius from $2.50 to near $4.50 in hopes of a positive early trial halt for Mino-Lok® (a rare but potential...
Adding Ehave (EHVFF) $0.04 to Psychedelic Watch List.
Mental Health and Wellness Incubator Set to Launch Four Initiatives.Trading at Year Low. Launching Clinical Trial With Brain Scientific to Monitor Ketamine Efficacy.Launching Clinical...
The FDA Cracks Down On Stem Cell Therapy.
Due to a somewhat unexpected crackdown on stem cell treatment centers a couple of weeks ago - we have decided to hold off launching...
Latest article
Could a Record El Niño Ignite the Next Vaccine Trade?
Chikungunya, Dengue Fever, Rift Valley Fever and Zika
The Coming El Niño: An Overlooked Catalyst for Vaccine Stocks?
Investors obsess over interest rates, tariffs and AI....
Party Time at UniQure (QURE)! From $8.86 to $47.21, up 432%.
I. No Bells, No Baskets.UniQure (QURE) $47 up Huge. Still Not Out Of The Woods!II.Replimune (REPL) $11.23. Gains 28% in Sympathy with UniQure. We...
Adding Bavarian Nordic (BVNRY) $8.91, to Watch List.
Bavarian Nordic Lands $106 Million Contract for its Smallpox/Mpox Vaccine!
Were Back for the Third Time!
LIVE QUOTE
PREVIOUS WRITEUPS
Aug 27, 2025: Our 4th Billion Dollar Takeover!...
